Hasija Amit 4
4 · Milestone Pharmaceuticals Inc. · Filed Jul 15, 2025
Insider Transaction Report
Form 4
Hasija Amit
CFO & EVP of Corp. Development
Transactions
- Award
Series B Common Warrants (right to buy)
2025-07-11+50,000→ 50,000 totalExercise: $1.88Exp: 2030-07-11→ Common Shares (50,000 underlying) - Award
Series A Common Warrants (right to buy)
2025-07-11+50,000→ 50,000 totalExercise: $1.50Exp: 2026-07-11→ Common Shares (50,000 underlying) - Award
Common Shares
2025-07-11+50,000→ 50,000 total
Footnotes (2)
- [F1]The reported securities are included within 50,000 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 50,000 shares of common stock.
- [F2]Fully vested and exercisable.